These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21184545)

  • 21. The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; He PC; Luo JF; Chen JY
    Int Urol Nephrol; 2012 Feb; 44(1):221-9. PubMed ID: 21336957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular morbidity and long term mortality associated with in hospital small increases of serum creatinine.
    Losito A; Nunzi E; Pittavini L; Zampi I; Zampi E
    J Nephrol; 2018 Feb; 31(1):71-77. PubMed ID: 28567702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
    Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term prognosis of acute kidney injury after first acute stroke.
    Tsagalis G; Akrivos T; Alevizaki M; Manios E; Theodorakis M; Laggouranis A; Vemmos KN
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):616-22. PubMed ID: 19211666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.
    Kafkas N; Liakos C; Zoubouloglou F; Dagadaki O; Dragasis S; Makris K
    Clin Cardiol; 2016 Aug; 39(8):464-70. PubMed ID: 27175937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study.
    Marcos EG; Geelhoed B; Van Der Harst P; Bakker SJL; Gansevoort RT; Hillege HL; Van Gelder IC; Rienstra M
    Europace; 2017 Dec; 19(12):1930-1936. PubMed ID: 28108549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
    Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
    J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
    Marenzi G
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):80-1. PubMed ID: 16265376
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry.
    Brown JR; Malenka DJ; DeVries JT; Robb JF; Jayne JE; Friedman BJ; Hettleman BD; Niles NW; Kaplan AV; Schoolwerth AC; Thompson CA
    Catheter Cardiovasc Interv; 2008 Sep; 72(3):347-354. PubMed ID: 18729173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
    Li WH; Li DY; Han F; Xu TD; Zhang YB; Zhu H
    Int Urol Nephrol; 2013 Aug; 45(4):1065-70. PubMed ID: 23225080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort.
    Schnabel RB; Seiffert M; Wilde S; Schirmer J; Koschyk DH; Conradi L; Ojeda F; Baldus S; Reichenspurner H; Blankenberg S; Treede H; Diemert P
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):440-7. PubMed ID: 24975883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.
    Kini AS; Sarkar K; Rafael OC; Jakkula M; Kaplish D; Lee P; Suleman J; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):49-55. PubMed ID: 19288579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
    Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
    Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
    Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Corin Level Is Associated With Subsequent Decline in Renal Function in Patients With Suspected Coronary Artery Disease.
    Yang SF; Chou RH; Li SY; Huang SS; Huang PH
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.